A method and system for separating and determining the residual quantity of four imidazole enantiomers in milk by using ultra-high performance liquid chromatography
By combining ultra-high performance phase chromatography with specific pretreatment and chiral chromatographic columns, the problem of separating tetraimidazole enantiomers in milk has been solved, enabling rapid and accurate enantiomer detection, improving detection efficiency and sensitivity, and making it suitable for quality control and risk assessment of dairy products.
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- HANGZHOU CUSTOMS TECHNICAL CENTER
- Filing Date
- 2026-05-12
- Publication Date
- 2026-07-17
AI Technical Summary
Existing technologies are difficult to rapidly and accurately separate and quantify the two enantiomers of tetraimidazole in milk, and are easily interfered with by impurities such as proteins and fats under complex matrix conditions, resulting in insufficient detection sensitivity and separation efficiency.
Ultra-high performance phase chromatography (UHPLC) combined with alkalization-salting-out ethyl acetate extraction and MCX solid-phase extraction purification was employed. An Acquity Trefoil CEL2 chiral column, supercritical carbon dioxide mobile phase, and 0.5% (v/v) ammonia-methanol solution modifier were used to achieve rapid and stable separation of tetraimidazole enantiomers, which were then quantified using a diode array detector.
It achieves efficient baseline separation, low matrix interference, high recovery rate and high sensitivity detection of tetraimidazole enantiomers in milk matrix, supporting accurate monitoring and risk assessment of tetraimidazole enantiomer residues in dairy products.
Smart Images

Figure CN122409903A_ABST